Home/Filings/4/0001225208-14-004319
4//SEC Filing

Covidien plc 4

Accession 0001225208-14-004319

CIK 0001385187operating

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:04 PM ET

Size

11.8 KB

Accession

0001225208-14-004319

Insider Transaction Report

Form 4
Period: 2014-02-11
King Brian Douglas
Vice President
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2014-02-11$42.39/sh+9,661$409,53046,772 total
  • Exercise/Conversion

    Ordinary Shares

    2014-02-11$39.18/sh+8,285$324,60655,057 total
  • Sale

    Ordinary Shares

    2014-02-11$70.00/sh17,946$1,256,22037,111 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-02-118,2858,286 total
    Exercise: $39.18Exp: 2020-11-30Ordinary Shares (8,285 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-02-119,66119,322 total
    Exercise: $42.39Exp: 2021-11-30Ordinary Shares (9,661 underlying)
Footnotes (3)
  • [F1]Also includes 83 shares acquired in connection with the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
  • [F2]Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
  • [F3]Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.

Documents

1 file

Issuer

Covidien plc

CIK 0001385187

Entity typeoperating

Related Parties

1
  • filerCIK 0001385187

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:04 PM ET
Size
11.8 KB